Utility of FOS as diagnostic marker for osteoid osteoma and osteoblastoma

Osteoid osteoma and osteoblastoma are bone-forming tumors shown to harbor FOS (87%) and FOSB (3%) rearrangements. The aim was to evaluate the immunohistochemical expression of FOS and FOSB in these tumors in comparison to other bone tumors, to evaluate the influence of decalcification, and to correl...

Descripción completa

Detalles Bibliográficos
Autores principales: Lam, Suk Wai, Cleven, Arjen H. G., Kroon, Herman M., Briaire-de Bruijn, Inge H., Szuhai, Karoly, Bovée, Judith V. M. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7085481/
https://www.ncbi.nlm.nih.gov/pubmed/31768625
http://dx.doi.org/10.1007/s00428-019-02684-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7085481/
https://www.ncbi.nlm.nih.gov/pubmed/31768625
http://dx.doi.org/10.1007/s00428-019-02684-9

Ejemplares similares